Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.
about
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyA synergistic effect of artocarpanone from Artocarpus heterophyllus L. (Moraceae) on the antibacterial activity of selected antibiotics and cell membrane permeabilityEvolution of antimicrobial peptides to self-assembled peptides for biomaterial applicationsType II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant PatientSurveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy.Genomic sequence of temperate phage Smp131 of Stenotrophomonas maltophilia that has similar prophages in xanthomonads.The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacterbaumannii.Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital.Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.Multidrug-resistant gram-negative bacteria infections in solid organ transplantation.New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt.Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.Stenotrophomonas maltophilia Serine Protease StmPr1 Induces Matrilysis, Anoikis, and Protease-Activated Receptor 2 Activation in Human Lung Epithelial Cells.Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis.Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria.
P2860
Q26782924-8F4FD2C6-25F2-4D03-A8CB-7443B3735777Q27014993-F6FA082F-C7FC-4D9E-9921-E9446BD9CD4BQ33675580-F7FCCBC9-FCEE-480E-969D-AD664ACADB43Q34809662-0B2DD37D-F4F8-4E85-AAD8-53936C30ACF1Q36053562-865D5266-5249-4D09-95B6-56E1917D7BADQ37203771-C3C8E3C5-E706-41A1-8584-5B906A4A81D2Q37366281-C9305380-5DF9-4E2C-BA02-538C24598C65Q37597229-BC69B92A-1423-45FE-9050-717A088A1A4BQ38130513-29F16EB2-03B8-47FA-A4A5-FCA41A110646Q40206558-BF07FA89-8D6F-486B-8F9C-0413F79CE565Q40303008-C21596B6-1276-49A2-A5BA-B84DF0637C50Q42003718-7E2E41DA-C033-42DD-9A03-7805DD813575Q42272359-51FBC8DD-F8F7-49F5-A6D3-897CC1FB224DQ45099898-5212CDBF-ABB4-48E6-8B7E-D3C41C536F05Q47117969-774251E5-EB1A-4928-AC3E-B77D1930D60EQ47661746-3D72E771-DDD6-4EAC-BD59-A078768D6D54Q47820779-E8134167-873A-4CD4-B04F-6F40F882BAE2Q50013423-3AEBD60B-F260-45AA-B14E-FB3C4D5237E0Q50928904-74407E1F-49B6-4A33-9275-3A3DE15289D4Q51026097-F7C174D1-AB57-4548-8152-F82FEB4727A5
P2860
Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination antimicrobial susc ...... from cystic fibrosis patients.
@ast
Combination antimicrobial susc ...... from cystic fibrosis patients.
@en
type
label
Combination antimicrobial susc ...... from cystic fibrosis patients.
@ast
Combination antimicrobial susc ...... from cystic fibrosis patients.
@en
prefLabel
Combination antimicrobial susc ...... from cystic fibrosis patients.
@ast
Combination antimicrobial susc ...... from cystic fibrosis patients.
@en
P2860
P356
P1476
Combination antimicrobial susc ...... from cystic fibrosis patients.
@en
P2093
K E N Milne
P2860
P304
P356
10.1128/AAC.00072-12
P407
P577
2012-05-14T00:00:00Z